Diagnostics criteria for arterial hypertension in conns disease
Reading Document
Medical Text Search
Conn's disease primary hyperaldosteronism arterial hypertension diagnostic criteria
Medical Text Search
primary aldosteronism screening confirmatory tests hypertension diagnosis
GradeResponse
GradeResponse
Medical Text Search
aldosterone renin ratio ARR cutoff primary aldosteronism screening hypertension
Medical Text Search
primary aldosteronism confirmatory testing salt loading fludrocortisone suppression test
Diagnostic Criteria for Arterial Hypertension in Conn's Disease (Primary Hyperaldosteronism)
Conn's disease refers to primary hyperaldosteronism (PA) — first described in 1957 — characterized by hypertension and inappropriately elevated plasma aldosterone independent of the renin-angiotensin system. Below is a structured diagnostic approach.
1. When to Suspect / Who to Screen
Screening for PA should be performed in hypertensive patients with any of the following:
| Indication | Details |
|---|---|
| Resistant hypertension | BP uncontrolled on ≥3 drugs including a diuretic |
| Spontaneous or diuretic-induced hypokalemia | K⁺ < 3.5 mmol/L |
| Hypertension + adrenal incidentaloma | Regardless of K⁺ level |
| Hypertension with onset < 40 years | Especially with family history |
| Hypertension + obstructive sleep apnea | |
| First-degree relative with PA | |
| Hypertensive patients with AF or stroke at young age |
BP thresholds that raise suspicion:
- Stage 2 hypertension (≥160/100 mmHg) or Stage 3 (≥180/110 mmHg)
- Drug-resistant hypertension (≥140/90 mmHg despite ≥3 agents)
2. Screening Test — Aldosterone-to-Renin Ratio (ARR)
The ARR is the primary screening tool (Endocrine Society Guidelines).
Conditions before testing:
- Correct hypokalemia
- Ensure adequate sodium intake
- Withdraw interfering medications for ≥4 weeks: spironolactone, eplerenone, amiloride, K⁺-wasting diuretics, licorice
- Withdraw for ≥2 weeks: ACE inhibitors, ARBs, dihydropyridine CCBs, β-blockers (which suppress renin and can falsely elevate ARR)
- Alpha-blockers (e.g., doxazosin) and verapamil are preferred antihypertensives during workup
ARR cutoff values (commonly used):
| Units | ARR Positive Threshold |
|---|---|
| ng/dL ÷ ng/mL/h (PAC/PRA) | ≥30 (with PAC ≥ 15 ng/dL) |
| pmol/L ÷ mIU/L | ≥70–100 (laboratory-dependent) |
A positive ARR alone is not diagnostic — confirmatory testing is required.
3. Confirmatory Tests (Positive Screening → Confirm PA)
At least one confirmatory test should be performed (unless spontaneous hypokalemia + undetectable renin + PAC > 20 ng/dL, which is sufficient):
| Test | Protocol | Positive Criterion |
|---|---|---|
| Oral sodium loading | 3 days high sodium diet (>200 mmol/day) + check 24h urine aldosterone | Urinary aldosterone > 12–14 µg/24h |
| Saline infusion test (SIT) | 2L 0.9% NaCl IV over 4h; measure PAC at 0 and 4h | PAC > 10 ng/dL post-infusion = positive; <5 ng/dL = negative |
| Fludrocortisone suppression test (FST) | Fludrocortisone 0.1 mg q6h × 4 days + NaCl; measure PAC on day 4 | PAC > 6 ng/dL (upright, 10 AM) with renin suppressed |
| Captopril challenge test | Captopril 25–50 mg PO; measure PAC at 0, 1–2h | PAC > 11 ng/dL or failure to suppress by ≥30% |
The saline infusion test is the most widely used in clinical practice.
4. Subtype Differentiation (After PA Confirmed)
| Method | Purpose |
|---|---|
| Adrenal CT scan | Identify adenoma vs. bilateral hyperplasia; CT alone insufficient for subtype |
| Adrenal vein sampling (AVS) | Gold standard — distinguishes unilateral adenoma (Conn's classic) from bilateral hyperplasia; lateralization ratio ≥2:1 (post-ACTH: ≥4:1) indicates unilateral disease |
CT alone misclassifies up to 37% of cases — AVS is required before surgical decision-making.
5. Biochemical Diagnosis Summary
A definitive diagnosis of PA requires:
- Hypertension (often resistant or severe)
- Elevated plasma aldosterone (PAC > 10–15 ng/dL)
- Suppressed plasma renin (PRA < 1 ng/mL/h or direct renin < 5–10 mIU/L)
- Positive ARR (≥30 using ng/dL / ng/mL/h)
- Confirmed by at least one suppression test
6. Associated Features Supporting the Diagnosis
- Hypokalemia (present in ~40% of PA; its absence does NOT exclude PA)
- Metabolic alkalosis
- Polyuria / nocturia (from K⁺ depletion)
- Muscle weakness / cramps
- Elevated urinary potassium excretion (urine K⁺ > 30 mmol/day despite hypokalemia)
Sources: Bailey & Love's Short Practice of Surgery, 28th ed. (p. 912); Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment — Endocrine Society / GLGCA Guidelines (p. 18); supplemented with Endocrine Society Clinical Practice Guideline 2016 (Funder et al.).
This is a shared conversation. Sign in to Orris to start your own chat.